[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600074":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":23,"locations":29,"responsibleParty":44,"collaborators":10,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":10,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":10,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Henan University of Science and Technology","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Adult patients with T1DM or T2DM",null,[12],"Device: GS3 CGM",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DEVICE","GS3 CGM","Wearing CGM for a consecutive 14 days",[9],[20],{"name":21,"affiliation":5,"role":22},"Hongwei Jiang","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Peng Liu","CONTACT","0379-64811993","peng.liu87@outlook.com",[30],{"facility":5,"status":31,"city":32,"state":33,"zip":34,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"RECRUITING","Luoyang","Henan","471003","China",{"type":37,"coordinates":38},"Point",[39,40],112.43684,34.67345,{"lat":40,"lon":39},[43],{"name":25,"role":26,"phone":10,"phoneExt":10,"email":28},{"type":22,"investigatorFullName":25,"investigatorTitle":45,"investigatorAffiliation":46,"oldNameTitle":10,"oldOrganization":10},"Physician","The First Affiliated Hospital of Henan University of Science and Technology","100600074",false,"NCT07092761","Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Diagonsed with T1DM or T2DM\n* Venous blood sampling access can be established in the forearm\n* Capable of independently reading instructions and complying with the clinical trial requirements\n* Willing to sign the Informed Consent Form (ICF)\n\nExclusion Criteria:\n\n* Severe hypoglycemia within the past 6 month\n* Heart failure or hemiplegic sequelae due to prior cerebrovascular disease\n* Severe skin conditions at the sensor wear site\n* Extensive systemic skin disorders\n* Coagulation disorders confirmed by the investigator\n* Anemia or abnormal hematocrit\n* Blood donation within the past 6 months\n* Pregnancy (defined as positive urine test in women ≤55 years), lactation, or plans for pregnancy within ≤30 days\n* Current or recent (≤1 month) participation in other clinical trials\n* Planned MRI\u002FCT scans during sensor wear\n* Allergy to medical adhesives or alcohol\n* Conditions impairing comprehension of informed consent or study procedures\n* Other exclusionary conditions per investigator's discretion","ALL","18 Years",{"count":55,"type":56},82,"ESTIMATED","INTERVENTIONAL",[59],"NA","The study is to evaluate the accuracy and safety of a novel real-time CGM system among adult patients with type 1 diabetes mellitus with respect to YSI reference venous plasma sample measurements.",[62],"Type1diabetes","2026-05-27",{"date":65,"type":66},"2026-05-29","ACTUAL",{"date":68,"type":66},"2025-04-01",{"date":70,"type":56},"2026-09-01",{"name":5,"class":6},1]